NASHVILLE, Tenn., Oct. 11, 2012 (GLOBE NEWSWIRE) -- Pathfinder Therapeutics, a developer of innovative surgical navigation products for soft tissue organs, announced today that Akron General Medical Center has implemented its advanced technology to treat liver cancer.
Dr. Kevin Lowe, a fellowship-trained specialist in Hepatobiliary Surgery performed the first cases using the novel advanced surgical planning and navigation platform from Pathfinder Therapeutics technology.
"Akron General is known for its breakthrough surgical procedures," said Dr. Lowe. "I am very pleased that we are now providing this unique technology for our patients."
"We are very excited to announce that our technology will be in use at Akron General to provide advanced liver cancer treatment options for patients in Ohio," stated Jim Cloar, CEO of Pathfinder. "This installation follows other leading cancer centers already utilizing our technology such as Memorial Sloan-Kettering Cancer Center, Barnes Jewish Hospital, The University of Pittsburgh Medical Center, The University of North Carolina, and The University of Louisville. Surgeons and hospitals are increasingly aware of how the use of state-of-the-art technology like Explorer can further distinguish their medical centers, as well as improve clinical outcomes for cancer patients. Additionally, we are very pleased to continue working with Dr. Lowe and the entire surgical team at Akron General."
Pathfinder is the first company to receive FDA clearance for a medical device to navigate liver surgery using pre-operative medical images. The Explorer system uses state-of-the-art line of sight localization and surface registration techniques to show surgeons where they are in the context of their target organ and surrounding anatomical structures. Pathfinder is dedicated to increasing the number and effectiveness of surgeries on soft tissue organs by improving surgical precision. The Explorer system allows surgeons to "see through" the organ they are operating on by registering the surgical instrument in three-dimensional space onto the patient's pre-operative medical images. In addition to Explorer, Pathfinder sells Scout, a software system for liver surgery planning. The Company is also developing an embodiment of Explorer to be used in minimally invasive surgical interventions in the liver. Beyond liver, Pathfinder is developing its application for use on the kidney and pancreas, as well as other organs. For more information, visit www.pathsurg.com.
About Akron General Health System
Akron General Health System is a not-for-profit healthcare organization with the mission of improving the health and lives of the people and communities it serves. Akron General Health System includes: Akron General Medical Center, a 511-bed teaching and research medical center, and Edwin Shaw Rehabilitation Institute, the area's largest provider of rehabilitation services; Akron General Partners, which includes Partners Physician Group, the Akron General Health & Wellness Centers, Lodi Community Hospital, Community Health Centers and other companies; Akron General Community Health Ventures, which includes Visiting Nurse Service and Affiliates, the largest and most comprehensive provider of home healthcare services in Ohio; and Akron General Foundation. Akron General has earned the prestigious National Research Corporation (NRC) Consumer Choice Award for 14 out of 16 years. Recently, U.S. News & World Report ranked Akron General Medical Center as the seventh best hospital in Ohio and Becker's Hospital Review named Akron General Medical Center one of the nation's top 100 hospitals. For more information about Akron General Health System, visit www.akrongeneral.org.
CONTACT: Pathfinder contact: Jim Cloar, 615-783-0094 Akron General contact: Jim Gosky, 330-344-6083Source: Pathfinder Therapeutics